GOLDMAN SACHS GROUP INC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 65 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$72,013
-66.7%
49,324
-47.7%
0.00%
Q2 2023$215,972
+1442.7%
94,311
+446.4%
0.00%
Q3 2022$14,000
-64.1%
17,261
-56.7%
0.00%
Q2 2022$39,000
-66.4%
39,850
-43.6%
0.00%
Q1 2022$116,000
-54.5%
70,595
-33.3%
0.00%
Q4 2021$255,000
+110.7%
105,805
+323.9%
0.00%
Q3 2021$121,000
+77.9%
24,958
-2.4%
0.00%
Q2 2021$68,000
-28.4%
25,583
-16.9%
0.00%
Q1 2021$95,000
-67.4%
30,804
-62.3%
0.00%
Q4 2020$291,000
-29.9%
81,754
-21.1%
0.00%
Q3 2020$415,000
+33.4%
103,558
-9.4%
0.00%
Q2 2020$311,000
+31.8%
114,280
+2.0%
0.00%
Q1 2020$236,000
-59.5%
112,065
+4.6%
0.00%
Q4 2019$583,000
+223.9%
107,176
+79.0%
0.00%
Q3 2019$180,000
-21.1%
59,883
-1.6%
0.00%
Q2 2019$228,000
+109.2%
60,832
+124.4%
0.00%
Q1 2019$109,000
-24.3%
27,103
-31.1%
0.00%
Q4 2018$144,000
-57.0%
39,357
+0.9%
0.00%
Q3 2018$335,000
-60.9%
39,013
-50.0%
0.00%
Q2 2018$856,000
+110.8%
77,975
+121.5%
0.00%
Q1 2018$406,000
+60.5%
35,205
+44.3%
0.00%
Q4 2017$253,000
+46.2%
24,395
+101.4%
0.00%
Q4 2016$173,000
-57.4%
12,110
-51.0%
0.00%
Q3 2016$406,000
+158.6%
24,690
+124.3%
0.00%
Q2 2016$157,000
-59.3%
11,010
-58.7%
0.00%
Q1 2016$386,00026,6430.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$28,105,0004.42%
Novo Holdings A/S 4,420,516$37,928,0003.01%
BVF INC/IL 1,890,507$16,221,0001.42%
Orbimed Advisors 5,967,584$51,202,0000.62%
COWEN INC. 588,706$5,051,0000.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,000$710,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 321,430$2,758,0000.32%
EcoR1 Capital, LLC 351,401$3,015,0000.27%
Rock Springs Capital Management LP 575,000$4,934,0000.18%
Hikari Power Ltd 32,090$275,0000.03%
View complete list of CORVUS PHARMACEUTICALS INC shareholders